InvestSMART

Acumentis Group Limited (ASX: ACU) - Announcements

- Current share price for ACU : $0.089

ASX company news and announcements for Acumentis Group Limited (ACU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Acumentis Group Limited (ACU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Acumentis Group Limited (ACU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Acumentis Group Limited (ACU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$20 Appendix 1A and Information Form and Checklist 13 May 2015 5:21PM $0.025 $0.089 risen by 256%
$20 Pre-Reinstatement Disclosure 13 May 2015 5:20PM $0.025 $0.089 risen by 256%
$20 ASX Reinstatement Notice 13 May 2015 5:20PM $0.025 $0.089 risen by 256%
$20 Reinstatement to Official Quotation (15 May 2015) 13 May 2015 5:20PM $0.025 $0.089 risen by 256%
$20 Appendix 3Y by 3 4 May 2015 4:56PM $0.025 $0.089 risen by 256%
$20 Appendix 3B 1 May 2015 6:36PM $0.025 $0.089 risen by 256%
$20 Appendix 4C - quarterly 30 Apr 2015 4:23PM $0.025 $0.089 risen by 256%
$20 Closure of Prospectus and Notification of change of name 24 Apr 2015 5:44PM $0.025 $0.089 risen by 256%
$20 Suspension from Official Quotation 11 Mar 2015 8:24PM n/a $0.089 n/a
$20 Response to ASX Query - Appendix 5B 20 Feb 2015 6:47PM n/a $0.089 n/a
$20 Activistic signs MoU with YuuZoo (Sgn) 2 Feb 2015 12:29PM $0.001 $0.089 risen by 8,800%
$20 Appendix 4C - quarterly 30 Jan 2015 4:27PM $0.001 $0.089 risen by 8,800%
$20 Shareholders Update 16 Jan 2015 2:16PM $0.001 $0.089 risen by 8,800%
$20 Loan facility extension 7 Nov 2014 8:13PM $0.001 $0.089 risen by 8,800%
$20 Appendix 4C - quarterly 30 Oct 2014 7:58PM $0.001 $0.089 risen by 8,800%
$20 Acuvax signs Agreement with Activistic 7 Oct 2014 7:58PM $0.001 $0.089 risen by 8,800%
$20 Preliminary Final Report YE 30 June 2014 27 Aug 2014 5:54PM $0.001 $0.089 risen by 8,800%
$20 Reinstatement to Official Quotation (26/08/2014) 25 Aug 2014 12:55PM $0.001 $0.089 risen by 8,800%
$20 Completion of Capital raising and prospectus 25 Aug 2014 12:55PM $0.001 $0.089 risen by 8,800%
$20 Suspension from Official Quotation 21 Mar 2013 4:36PM $0.001 $0.089 risen by 8,800%
$20 Appendix 4D and Half Year Financial Report 25 Feb 2013 2:50PM $0.001 $0.089 risen by 8,800%
$20 Binding Agreement to acquire Biolife Science Ltd 12 Feb 2013 2:46PM $0.001 $0.089 risen by 8,800%
$20 Appendix 4C - quarterly 31 Jan 2013 3:48PM $0.001 $0.089 risen by 8,800%
$20 Acquisition of cancer immunotherapy company 20 Dec 2012 9:37AM $0.001 $0.089 risen by 8,800%
$20 Trading Halt 19 Dec 2012 2:43PM $0.001 $0.089 risen by 8,800%

451 - 475 of 605 results

Page 19 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.